SURMODICS, INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1979-01-01
- Employees
- 376
- Market Cap
- -
- Website
- http://www.surmodics.com
Pounce™ Thrombectomy System Retrospective Registry
- Conditions
- Peripheral Arterial DiseaseAcute Limb Ischemia
- Interventions
- Device: Pounce Thrombectomy System
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05868161
- Locations
- 🇺🇸
OSF St. Francis Medical Center, Peoria, Illinois, United States
🇺🇸Community Hospital, Munster, Indiana, United States
🇺🇸Baton Rouge General Medical Center, Baton Rouge, Louisiana, United States
SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study
- Conditions
- Peripheral Vascular Occlusive Disease
- Interventions
- Device: Pounce Venous Thrombectomy System
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05600816
Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon
- Conditions
- Critical Lower Limb IschemiaPeripheral Arterial Disease
- Interventions
- Device: SUNDANCE™ Drug Coated Balloon
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04107298
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Australia
🇩🇪MEDINOS Kliniken des Landkreises Sonneberg GmbH, Sonneberg, Germany
🇳🇿Auckland City Hospital, Auckland, New Zealand
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)
- Conditions
- Hemodialysis Access Failure
- Interventions
- Device: SurVeil Drug Coated Balloon
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03734679
- Locations
- 🇦🇺
Prince of Wales Private Hospital, Randwick, New South Wales, Australia
🇳🇿Auckland City Hospital, Auckland, New Zealand
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
- Conditions
- Peripheral Vascular DiseaseFemoropopliteal Artery OcclusionArtery Disease, PeripheralPeripheral Arterial Disease
- Interventions
- Device: Medtronic IN.PACT Admiral DCBDevice: Surmodics SurVeil DCB
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 446
- Registration Number
- NCT03241459
- Locations
- 🇺🇸
Bryn Mawr Hospital - Main Line Health System (Einstein), Philadelphia, Pennsylvania, United States
🇺🇸MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸Advocate Health, Naperville, Illinois, United States
Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon
- Conditions
- Peripheral Arterial DiseasePeripheral Vascular Diseases
- Interventions
- Device: SurVeil Drug Coated BalloonProcedure: Angioplasty
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02648620
- Locations
- 🇺🇸
Wellmont Health System, Kingsport, Tennessee, United States
🇺🇸OhioHealth Research Institute, Columbus, Ohio, United States
🇺🇸NC Heart and Vascular Research, Raleigh, North Carolina, United States
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT00915837
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸California Retina Consultants, Santa Barbara, California, United States
🇺🇸VitreoRetinal Surgery, PA, Edina, Minnesota, United States